Skip to main content

letter

. 1989 Jun 10;298(6687):1581–1582. doi: 10.1136/bmj.298.6687.1581-c

Beta blockers and carbohydrate and lipoprotein metabolism in hypertensive patients.

J M Cruickshank

PMCID: PMC1836823 PMID: 2569336

1581

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Cruickshank J. M., Pennert K., Sörman A. E., Thorp J. M., Zacharias F. M., Zacharias F. J. Low mortality from all causes, including myocardial infarction, in well-controlled hypertensives treated with a beta-blocker plus other antihypertensives. J Hypertens. 1987 Aug;5(4):489–498. [PubMed] [Google Scholar]
Kaplan J. R., Manuck S. B., Adams M. R., Weingand K. W., Clarkson T. B. Inhibition of coronary atherosclerosis by propranolol in behaviorally predisposed monkeys fed an atherogenic diet. Circulation. 1987 Dec;76(6):1364–1372. doi: 10.1161/01.cir.76.6.1364. [DOI] [PubMed] [Google Scholar]
Pick R., Glick G. Effects of propranolol, minoxidil, and clofibrate on cholesterol-induced atherosclerosis in stumptail macaques (Macaca arctoides). Atherosclerosis. 1977 May;27(1):71–77. doi: 10.1016/0021-9150(77)90026-0. [DOI] [PubMed] [Google Scholar]
Pollare T., Lithell H., Selinus I., Berne C. Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients. BMJ. 1989 Apr 29;298(6681):1152–1157. doi: 10.1136/bmj.298.6681.1152. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES